Interaction between antidepressants and perphenazine in psychiatric inpatients
- 1 October 1982
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 139 (10), 1329-1331
- https://doi.org/10.1176/ajp.139.10.1329
Abstract
In a study of 99 patients receiving amitriptyline or nortriptyline alone and 60 patients receiving 1 of these antidepressants in combination with perphenazine, the patients receiving the combination medication had up to 70% higher antidepressant plasma levels than patients receiving the antidepressant alone. The groups did not differ significantly in sex, age, smoking behavior or antidepressant dose level. Due to the possibility of side effects from such a combination of medication, depressed patients not responding to the tertiary amine tricyclic antidepressants evidently receive a trial of high doses of the drugs before antidepressant-neuroleptic combinations are administered.This publication has 9 references indexed in Scilit:
- Clinical response and plasma concentration of amitriptyline and its metabolite nortriptylineEuropean Journal of Clinical Pharmacology, 1978
- Therapeutic monitoring of tricyclic antidepressants in plasma by gas chromatography.Clinical Chemistry, 1977
- Clinical Implications of Imipramine Plasma Levels for Depressive IllnessArchives of General Psychiatry, 1977
- Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptylineEuropean Journal of Clinical Pharmacology, 1977
- Plasma levels and antidepressive effect of imipramineClinical Pharmacology & Therapeutics, 1976
- Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levelsPsychopharmacology, 1976
- PLASMA-NORTRIPTYLINE LEVELS IN ENDOGENOUS DEPRESSIONThe Lancet, 1973
- Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in ManBMJ, 1972
- Relationship between Plasma Level and Therapeutic Effect of NortriptylineBMJ, 1971